Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Intellipharmaceutics International Inc (IPCI.TO)

Intellipharmaceutics International Inc (IPCI.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 2,647
  • Shares Outstanding, K 33,093
  • Annual Sales, $ 66 K
  • Annual Income, $ -2,892 K
  • 60-Month Beta 0.76
  • Price/Sales 2.38
  • Price/Cash Flow 17.91
  • Price/Book N/A
Trade IPCI.TO with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.09
  • Most Recent Earnings $-0.06 on N/A
  • Latest Earnings Date 10/13/23
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    SIC-2834 Pharmaceutical Preparations

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0650 +23.08%
on 02/28/24
0.0950 -15.79%
on 03/05/24
-0.0100 (-11.11%)
since 02/02/24
3-Month
0.0600 +33.33%
on 01/22/24
0.1250 -36.00%
on 12/11/23
-0.0350 (-30.43%)
since 12/05/23
52-Week
0.0400 +100.00%
on 06/22/23
0.1350 -40.74%
on 07/31/23
unch (unch)
since 02/22/23

Most Recent Stories

More News
Intellipharmaceutics: Fiscal Q3 Earnings Snapshot

Intellipharmaceutics: Fiscal Q3 Earnings Snapshot

IPCI.TO : 0.0800 (-11.11%)
Intellipharmaceutics: Fiscal Q2 Earnings Snapshot

Intellipharmaceutics: Fiscal Q2 Earnings Snapshot

IPCI.TO : 0.0800 (-11.11%)
Stocks in play: Intellipharmaceutics International Inc.

Today reported the results of operations for the year ended November 30. All dollar amounts referenced ...

IPCI.TO : 0.0800 (-11.11%)
Intellipharmaceutics: Fiscal Q4 Earnings Snapshot

Intellipharmaceutics: Fiscal Q4 Earnings Snapshot

IPCI.TO : 0.0800 (-11.11%)
Intellipharmaceutics: Fiscal Q1 Earnings Snapshot

Intellipharmaceutics: Fiscal Q1 Earnings Snapshot

IPCI.TO : 0.0800 (-11.11%)
Intellipharmaceutics Announces Fiscal Year 2022 and First Quarter 2023 Results

/CNW/ - Intellipharmaceutics International Inc. (OTCQB: IPCIF) (TSX: IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in...

IPCIF : 0.0600 (unch)
IPCI.TO : 0.0800 (-11.11%)
Intellipharmaceutics Announces Cease Trade Order

/CNW/ - Intellipharmaceutics International Inc. (OTCQB: IPCIF) (TSX: IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in...

IPCIF : 0.0600 (unch)
IPCI.TO : 0.0800 (-11.11%)
Intellipharmaceutics Provides Update on Management Cease Trade Order Application and Anticipates Cease Trade Order

/CNW/ - Intellipharmaceutics International Inc. (OTCQB: IPCIF) (TSX: IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in...

IPCIF : 0.0600 (unch)
IPCI.TO : 0.0800 (-11.11%)
Intellipharmaceutics Announces its Expected Delay in Filing Annual Audited Financial Statements and Annual Information Form and its Management Cease Trade Order Application

/CNW/ - Intellipharmaceutics International Inc. (OTCQB: IPCIF) (TSX: IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in...

IPCIF : 0.0600 (unch)
IPCI.TO : 0.0800 (-11.11%)
Intellipharmaceutics Announces Second Quarter 2022 Results

TORONTO, ON / ACCESSWIRE / July 21, 2022 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research,...

IPCIF : 0.0600 (unch)
IPCI.TO : 0.0800 (-11.11%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar